Volume | 129,361 |
|
|||||
News | - | ||||||
Day High | 1.11 | Low High |
|||||
Day Low | 1.04 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Quince Therapeutics Inc | QNCX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.05 | 1.04 | 1.11 | 1.11 | 1.06 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
597 | 129,361 | $ 1.07 | $ 138,642 | - | 0.84 - 1.74 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:43:28 | 2 | $ 1.06 | USD |
Quince Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
83.59M | 42.87M | - | 0 | -31.39M | -0.73 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Quince Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QNCX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.00 | 1.11 | 0.95 | 1.02 | 129,916 | 0.11 | 11.00% |
1 Month | 1.25 | 1.25 | 0.89 | 1.02 | 92,548 | -0.14 | -11.20% |
3 Months | 1.16 | 1.42 | 0.89 | 1.16 | 69,574 | -0.05 | -4.31% |
6 Months | 0.9718 | 1.4301 | 0.84 | 1.11 | 79,452 | 0.1382 | 14.22% |
1 Year | 1.53 | 1.74 | 0.84 | 1.24 | 140,865 | -0.42 | -27.45% |
3 Years | 38.52 | 121.98 | 0.5401 | 10.97 | 616,845 | -37.41 | -97.12% |
5 Years | 20.00 | 121.98 | 0.5401 | 15.29 | 434,932 | -18.89 | -94.45% |
Quince Therapeutics Description
Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States. |